Vipergen
PrivateCompany Overview
Vipergen operates in Healthcare & Life Sciences and is based in Copenhagen. It was founded in 2005.
Vipergen is a biotechnology company that provides small molecule drug discovery services based on DNA-encoded library (DEL) technologies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vipergen Comparables
Compare Vipergen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| X-Chem | 87% | |
| NovAliX | 86% | |
| HitGen Inc. | 81% |
For institutional investors. Book with your work email.
Vipergen Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 16, 2025
Grew 25% QoQ from 12 to 15 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withSep 1, 2026
On Sep 4th '26 in the United Kingdom and Denmark, Vipergen integrates with Domainex to give clients access to DEL screening alongside fragment-based and high-throughput screening, assay development, biophysics, and medicinal chemistry capabilities for lead discovery programmes.
- launchesAug 28, 2026
On Aug 28th '26, Vipergen releases updated DEL libraries Lib059 and Lib101 with expanded chemical diversity, together providing more than 1.3 billion small molecules for screening.
For institutional investors. Book with your work email.
Vipergen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vipergen's valuation, stock price, and market status.
Is Vipergen a public or private company?
Vipergen is a private company.
What is the current stock price of Vipergen?
Vipergen is a private company, so its shares have no public market price. Caplight tracks Vipergen's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vipergen worth (valuation)?
Valuation information for Vipergen is not publicly available.
Can I buy Vipergen stock?
Vipergen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vipergen's last funding round?
Funding round information for Vipergen is not publicly available.
Who are the main investors in Vipergen?
Investor information for Vipergen is not publicly disclosed.
Will Vipergen IPO soon?
No public IPO plans have been announced for Vipergen.
How can I track Vipergen secondary market activity?
Caplight tracks bids, offers, and trades in Vipergen's shares on secondary markets.